子社群 于重元 [19/19] 劉柯俊 [87/107] 劉滄梧 [120/126] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [85/97] 常慧如 [40/45] 張俊彥 [234/254] 張光裕 [70/80] 張憶壽 [104/107] 張文祥 [52/54] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/47] 李家惠 [29/29] 李岳倫 [49/55] 林素芳 [32/32] 楊奕馨 [44/45] 江士昇 [90/92] 沈哲宏 [14/16] 洪文俊 [88/92] 莊雙恩 [82/91] 蔡坤志 [32/35] 蔡慧珍 [67/85] 蘇勇曄 [41/41] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [46/49] 陳振陽 [72/72] 陳立宗 [447/518] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [39/40] 黃智興 [56/57] 黃道揚 [27/27] 丁兆治(2000-2004) [5/5] 其他 [470/478] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/56] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 邻近社群 分子與基因醫學研究所 [930/995] 生技與藥物研究所 [846/1109] 生醫工程與奈米醫學研究所 [1230/1426] 免疫醫學研究中心 [232/267] 神經及精神醫學研究中心 [803/856] 細胞及系統醫學研究所 [763/857] 感染症與疫苗研究所 [1559/1687] 群體健康科學研究所 [2910/3045] 國家環境醫學研究所 [1579/1615] 國家蚊媒傳染病防治研究中心 [105/108] 高齡醫學暨健康福祉研究中心 [256/265] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [198/201] 核心儀器設施中心 [9/9] 病理核心實驗室 [15/15] 實驗動物中心 [9/9] 行政管理部門 [19/19] 社群统计 近3年内发表的文件:232(9.42%) 含全文笔数:2275(92.37%) 文件下载次数统计 下载大于0次:2275(100.00%) 下载大于100次:2275(100.00%) 全文下载总次数:1669256(29.41%) 最后更新时间: 2025-03-02 06:31 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Outdoor activity during class reces... Prognostic significance of diagnosi... Durvalumab, tremelimumab, and plati... Is postoperative adjuvant therapy n... Comparative impact of tertiary lymp... Syngeneic natural killer cell thera... Intercellular TIMP-1-CD63 signaling... The correlation between LAG-3 expre... Downregulation of PAX1 in OSCC Enha... Reprogramming dysfunctional dendrit...

跳至: (选择年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1151-1175 / 2463. (共99页) << < 42 43 44 45 46 47 48 49 50 51 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2016-02-10	Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer	Scientific Reports. 2016 Feb 10;6:Article number 20701.
2016-02	Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial	Lancet. 2016 Feb;387(10018):545-557.
2016-02	Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells	RNA. 2016 Feb;22(2):303-315.
2016-02	JAK2 overexpression is a prognostic indicator for worse outcome in nasopharyngeal carcinoma and is independent of JAK2 exon 12 and JAK2 V617F mutation	Laboratory Investigation. 2016 Feb;96(Suppl. 1):325A.
2016-02	Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	Oncology Research and Treatment. 2016 Feb;39(Suppl. 1):170.
2016-02	JAK2 overexpression is a prognostic indicator for worse outcome in nasopharyngeal carcinoma and is independent of JAK2 exon 12 and JAK2 V617F mutation	Modern Pathology. 2016 Feb;29(Suppl. 2):325A.
2016-02	Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway	American Journal of Cancer Research. 2016 Feb;6(3):628-638.
2016-02	Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 134.
2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
2016-02	A randomized, open-label phase II study of nanoliposomal irinotecan (nal-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine in patients with previously untreated metastatic pancreatic adenocarcinoma (mPAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract TPS482.
2016-02	Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 417.
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
2016-01-29	SPOCK1 overexpression confers a poor prognosis in urothelial carcinoma	Journal of Cancer. 2016 Jan 29;7(4):467-476.
2016-01-10	Necdin overexpression predicts poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder	Journal of Cancer. 2016 Jan 10;7(3):304-313.
2016-01-07	Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement with bland cytological features mimicking desmoid-type fibromatosis: A case report and review of the literature	Oncology Letters. 2016 Jan 7;11(2):1429-1434.
2016-01-04	Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women	Human Molecular Genetics. 2016 Jan 4;25(3):620-629.
2016-01	IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia	Journal of Leukocyte Biology. 2016 Jan;99(1):131-141.
2016-01	The novel VEGF121-VEGF165 fusion attenuates angiogenesis and drug resistance via targeting VEGFR2-HIF-1alpha-VEGF165/Lon signaling through PI3K-AKT-mTOR pathway	Current Cancer Drug Targets. 2016 Jan;6(3):275-286.
2016-01	The role of wnt signaling in squamous cell carcinoma	Journal of Dental Research. 2016 Jan;95(2):129-134.
2016-01	Investigating the association between periodontal disease and risk of pancreatic cancer	Pancreas. 2016 Jan;45(1):134-141.
2016-01	2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition	Organic and Biomolecular Chemistry. 2016 Jan;14(2):716-723.
2016-01	S-1 with leucovorin for gastric cancer: How far can it go?	Lancet Oncology. 2016 Jan;17(1):12-14.
2016-01	The prognostic significance of inflammation-associated blood cell markers in patients with upper tract urothelial carcinoma	Annals of Surgical Oncology. 2016 Jan;23(1):343-351.
2016-01	A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial	Medicine. 2016 Jan;95(3):Article number e2565.
2015-12-24	Assessment of the immunomodulatory properties of human mesenchymal stem cells (MSCs)	Journal of Visualized Experiments. 2015 Dec 24;2015(106):Article number e53265.

显示项目1151-1175 / 2463. (共99页) << < 42 43 44 45 46 47 48 49 50 51 > >> 每页显示[10|25|50]项目